AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
10.97
+0.61 (5.89%)
At close: Aug 13, 2026, 4:00 PM EDT
10.96
-0.01 (-0.09%)
After-hours: Aug 13, 2026, 7:59 PM EDT
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $3.36 billion as of August 13, 2026. Its market cap has increased by 163.60% in one year.
Market Cap
3.36B
Enterprise Value
2.96B
1-Year Change
163.60%
Ranking
Category
Stock Price
$10.97
ChartMarket Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $3.36B, a decrease of -78.53%. That is a compound annual growth rate of -23.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 3.36B | 228.56% |
| Dec 31, 2025 | 1.02B | 18.29% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arcus Biosciences | 3.67B |
| IDEAYA Biosciences | 3.54B |
| Celldex Therapeutics | 3.35B |
| uniQure | 3.26B |
| Arcutis Biotherapeutics | 3.25B |
| MBX Biosciences | 3.23B |
| NewAmsterdam Pharma Company | 3.19B |
| Alumis | 3.11B |